Pharma and engineering stocks surge on listing; aviation sector lags

Symbiotech Pharmalab and Hy-Tech Engineers delivered robust performances in their market debuts, providing fresh impetus to India's initial public offering rally that has shown resilience in recent weeks. Both companies listed at substantial premiums to their issue prices, rewarding investors who subscribed to their share offerings.

The pharmaceutical and engineering sector stocks' strong showings contrast with weakness in the broader market, as aviation-focused Skyways Air failed to generate investor enthusiasm on its listing. The divergence highlights the selective nature of current market sentiment, with investors gravitating toward sectors perceived to offer stronger fundamentals and growth prospects.

Subscription data ahead of the listings revealed considerable investor appetite across the IPO pipeline. Software and jewellery sector offerings, including ESDS Software and Priority Jewels, reportedly garnered triple-digit oversubscription, indicating robust demand for equity issuances across diverse industry segments.

The ongoing IPO activity reflects continued confidence in India's economic trajectory despite macroeconomic headwinds. Market participants are closely monitoring whether this momentum can be sustained as more companies approach the primary market in coming weeks. The selectivity shown by investors suggests a preference for quality issuers with proven business models and growth visibility.